Novus Biologicals™ Recombinant Human CXCL13/BLC/BCA-1 Protein

Catalog No.	Quantity
NB002056	100 μg

Catalog No. NB002056 Supplier Novus Biologicals™ Supplier No. NBP199658100UG

Description

Highly purified and high bioactivity. Generating reliable and reproducible results.

Recombinant bioactive protein containing 85 amino acids for Human CXCL13/BLC/BCA-1 The Recombinant Human CXCL13/BLC/BCA-1 Protein is derived from E. coli. The Recombinant Human CXCL13/BLC/BCA-1 Protein has been validated for the following applications: SDS-Page, Bioactivity.

Specifications

• Concentration: Lyoph
• For Use With (Application): Bioactivity, SDS-PAGE
• Formulation: Sterile filtered and lyophilized from 10 mM TFA (trifluoroacetic acid).
• Gene ID (Entrez): 10563
• Molecular Weight (g/mol): 10.1 kDa
• Quantity: 100 μg
• Source: E. coli
• Storage Requirements: Store at -20°C. Avoid freeze-thaw cycles.
• Gene Alias: ANGIE, ANGIE2, B cell-attracting chemokine 1, B lymphocyte chemoattractant, BCA1B-cell chemoattractant, BCA-1CXC chemokine BLC, B-cell-homing chemokine (ligand for Burkitt's lymphoma receptor-1), BLCSmall-inducible cytokine B13, BLR1L, B-lymphocyte chemoattractant, chemokine (C-X-C motif) ligand 13, chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant), C-X-C motif chemokine 13, SCYB13B-cell-attracting chemokine 1, small inducible cytokine B subfamily (Cys-X-Cys motif), member 13 (B-cellchemoattractant)
• Gene Symbol: CXCL13
• Reconstitution: Centrifuge the vial prior to opening. Reconstitute in H2O to a concentration of 0.1 - 1 mg/mL. The solution can then be diluted into other aqueous buffers or stored at 4°C for 1 week or -20°C for long-term storage.
• Buffer: Sterile filtered and lyophilized from 10 mM TFA (trifluoroacetic acid).
• Endotoxin Level: <0.1 ng/μg
• Purity or Quality Grade: >95%, by SDS-PAGE